Literature DB >> 10916139

Natural and designer binding sites made by phage display technology.

H R Hoogenboom1, P Chames.   

Abstract

In the past decade, the drive to develop completely human antibodies for human therapy has led to the development of phage display technology. This technology is able to deliver the ultimate in antibody engineering, that is, high-affinity fully human antibodies to any antigen of choice. Here, this application of phage display technology is reviewed, and the many other antibody-engineering avenues this technology offers are highlighted.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10916139     DOI： 10.1016/s0167-5699(00)01667-4

Source DB:  PubMed          Journal:  Immunol Today        ISSN： 0167-5699


  25 in total

Review 1.  Generation and production of engineered antibodies.

Authors:  Sergey M Kipriyanov; Fabrice Le Gall
Journal:  Mol Biotechnol       Date:  2004-01       Impact factor: 2.695

Review 2.  Demystified...recombinant antibodies.

Authors:  K A Smith; P N Nelson; P Warren; S J Astley; P G Murray; J Greenman
Journal:  J Clin Pathol       Date:  2004-09       Impact factor: 3.411

Review 3.  Continuing pursuit for ideal systemic anticancer radiotherapeutics.

Authors:  Marlein Miranda Cona; Huaijun Wang; Junjie Li; Yuanbo Feng; Feng Chen; Peter de Witte; Alfons Verbruggen; Yicheng Ni
Journal:  Invest New Drugs       Date:  2011-10-18       Impact factor: 3.850

Review 4.  Therapeutic antibodies: successes, limitations and hopes for the future.

Authors:  Patrick Chames; Marc Van Regenmortel; Etienne Weiss; Daniel Baty
Journal:  Br J Pharmacol       Date:  2009-05       Impact factor: 8.739

5.  One-step detection of aflatoxin-B(1) using scFv-alkaline phosphatase-fusion selected from human phage display antibody library.

Authors:  Kuntalee Rangnoi; Nanthnit Jaruseranee; Richard O'Kennedy; Potjamas Pansri; Montarop Yamabhai
Journal:  Mol Biotechnol       Date:  2011-11       Impact factor: 2.695

6.  Screening specific polypeptides of breast cancer stem cells from a phage display random peptide library.

Authors:  Fei Liu; Chun-Ling Qi; Mian Kong; Ting-Ting Liu; Lei Li; Bao-Jiang Li
Journal:  Oncol Lett       Date:  2016-10-13       Impact factor: 2.967

7.  Phage-displayed combinatorial peptide libraries in fusion to beta-lactamase as reporter for an accelerated clone screening: Potential uses of selected enzyme-linked affinity reagents in downstream applications.

Authors:  Girja S Shukla; David N Krag
Journal:  Comb Chem High Throughput Screen       Date:  2010-01       Impact factor: 1.339

8.  An improved helper phage system for efficient isolation of specific antibody molecules in phage display.

Authors:  Hyunjung Baek; Kyoung-ho Suk; Yong-hwan Kim; Sanghoon Cha
Journal:  Nucleic Acids Res       Date:  2002-03-01       Impact factor: 16.971

9.  The use of phage display to generate conformation-sensor recombinant antibodies.

Authors:  Aftabul Haque; Nicholas K Tonks
Journal:  Nat Protoc       Date:  2012-11-15       Impact factor: 13.491

10.  VH3 gene usage in neutralizing human antibodies specific for the Entamoeba histolytica Gal/GalNAc lectin heavy subunit.

Authors:  Hiroshi Tachibana; Katsuomi Watanabe; Xun-Jia Cheng; Hideo Tsukamoto; Yoshimasa Kaneda; Tsutomu Takeuchi; Seiji Ihara; William A Petri
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.